跳至主要内容
临床试验/NCT00145275
NCT00145275已完成3 期

To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women

Novartis5 个研究点 分布在 5 个国家目标入组 455 人开始时间: 2004年12月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Novartis
入组人数
455
试验地点
5
主要终点
Temperature increase

研究概览

简要总结

Zoledronic acid is a medicine being studied in people with low bone mass. Side effects such as headache, fever, muscle aches, and pains, may occur following the infusion. This study will investigate the use of over-the-counter medicines to improve these symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women greater than or equal to 45 years and less than or equal to 75 years of age inclusive
  • Low bone mineral density

排除标准

  • Certain prior treatments for low bone mass/osteopenia
  • Current use of medicines (prescription or non-prescription) for pain, fever, or inflammation
  • Impaired kidney function
  • Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

Temperature increase

次要结局

  • Questionnaires
  • VAS (visual analog scale)

研究者

发起方
Novartis
申办方类型
Industry

研究点 (5)

Loading locations...

相似试验

To Assess the Efficacy of Over-the-counter... | 临床试验